Your browser doesn't support javascript.
loading
Tyrosine kinase SYK is a potential therapeutic target for liver fibrosis.
Qu, Chen; Zheng, Dandan; Li, Sai; Liu, Yingjun; Lidofsky, Anna; Holmes, Jacinta A; Chen, Jianning; He, Lu; Wei, Lan; Liao, Yadi; Yuan, Hui; Jin, Qimeng; Lin, Zelong; Hu, Qiaoting; Jiang, Yuchuan; Tu, Mengxian; Chen, Xijun; Li, Weiming; Lin, Wenyu; Fuchs, Bryan C; Chung, Raymond T; Hong, Jian.
Affiliation
  • Qu C; Department of Abdominal Surgery, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, China.
  • Zheng D; Cancer Center, Southern Medical University, Guangzhou, China.
  • Li S; Department of Abdominal Surgery, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, China.
  • Liu Y; Cancer Center, Southern Medical University, Guangzhou, China.
  • Lidofsky A; Department of Pharmacy, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, China.
  • Holmes JA; Department of General Surgery, Affiliated Tumor Hospital of Zhengzhou University, Zhengzhou, China.
  • Chen J; Gastrointestinal Unit, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
  • He L; Gastrointestinal Unit, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
  • Wei L; Department of Pathology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
  • Liao Y; Department of Abdominal Surgery, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, China.
  • Yuan H; Cancer Center, Southern Medical University, Guangzhou, China.
  • Jin Q; Division of Surgical Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA.
  • Lin Z; Department of Abdominal Surgery, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, China.
  • Hu Q; Cancer Center, Southern Medical University, Guangzhou, China.
  • Jiang Y; Department of Abdominal Surgery, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, China.
  • Tu M; Cancer Center, Southern Medical University, Guangzhou, China.
  • Chen X; Department of Abdominal Surgery, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, China.
  • Li W; Cancer Center, Southern Medical University, Guangzhou, China.
  • Lin W; Department of Abdominal Surgery, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, China.
  • Fuchs BC; Cancer Center, Southern Medical University, Guangzhou, China.
  • Chung RT; Department of Abdominal Surgery, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, China.
  • Hong J; Cancer Center, Southern Medical University, Guangzhou, China.
Hepatology ; 68(3): 1125-1139, 2018 09.
Article in En | MEDLINE | ID: mdl-29537660
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Pyrazines / Hepatic Stellate Cells / Syk Kinase / Indazoles / Liver Cirrhosis, Experimental Type of study: Prognostic_studies Limits: Animals / Humans / Male Language: En Journal: Hepatology Year: 2018 Type: Article Affiliation country: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Pyrazines / Hepatic Stellate Cells / Syk Kinase / Indazoles / Liver Cirrhosis, Experimental Type of study: Prognostic_studies Limits: Animals / Humans / Male Language: En Journal: Hepatology Year: 2018 Type: Article Affiliation country: China